Julia Lainster

Julia Lainster

HealthTech Solutions Expert
Julia Lainster is an expert in Healthtech with a focus on electronic health records, interoperability standards, and cybersecurity. Her content is geared toward industry leaders and organizations seeking to leverage technology to improve efficiency, accuracy, and security in healthcare delivery. Julia aims to drive digital transformation and innovation in Healthtech.
Are NHS Trusts Endangering Patients by Ignoring Digital Safety Standards?
Research & Development Are NHS Trusts Endangering Patients by Ignoring Digital Safety Standards?

Recently, concerns have been raised by Clinical Safety Officers (CSOs) regarding the potential risks to patient safety due to NHS trusts' historical non-compliance with digital clinical safety standards. A BBC investigation revealed that 126 cases of serious harm, including three fatalities, were

Thermo Fisher CEO Predicts Expansion and Growth Amid GLP-1 Demand Surge
Biotech & Bioprocessing Thermo Fisher CEO Predicts Expansion and Growth Amid GLP-1 Demand Surge

In an optimistic outlook at the 43rd JPM Conference in San Francisco, Thermo Fisher CEO Marc Casper underscored the firm's strategic adaptations and growth initiatives tailored to meet surging demand for GLP-1 diabetes and weight loss products. Thermo Fisher Scientific's extensive investment in its

Can Robotic Automation Revolutionize Laboratory Efficiency and Precision?
Tech & Innovation Can Robotic Automation Revolutionize Laboratory Efficiency and Precision?

With the rapid advancement of technology, laboratories are increasingly seeking innovative solutions to improve their efficiency and precision, thereby reducing errors and streamlining workflows. At the SLAS 2025 International Conference & Exhibition in San Diego, ABB Robotics is preparing to

Are Anatomic Lung Resections Superior for Stage 1A NSCLC Survival?
Research & Development Are Anatomic Lung Resections Superior for Stage 1A NSCLC Survival?

Recent research presented at the 2025 Society of Thoracic Surgeons (STS) Annual Meeting has shed light on the survival benefits of anatomic lung resections, specifically lobectomy and segmentectomy, for patients diagnosed with stage 1A non-small cell lung cancer (NSCLC). Utilizing data from the STS

AI's Impact on Drug Development: Unseen Challenges and Limited Success
Research & Development AI's Impact on Drug Development: Unseen Challenges and Limited Success

The transformative potential of Artificial Intelligence (AI) in the field of therapeutics, particularly drug development, has been a topic of significant excitement and investment. However, despite the enthusiasm, tangible evidence of AI's success in revolutionizing drug development remains

Can New Stem Cell Discovery Revolutionize Glioblastoma Treatment?
Tech & Innovation Can New Stem Cell Discovery Revolutionize Glioblastoma Treatment?

A recent study has unveiled a new type of stem cell in the brain that could potentially revolutionize treatments for adult glioblastoma (GBM), a highly lethal brain tumor. Conducted by a team led by Li Wang and guided by senior author Arnold Kriegstein at the University of California, San Francisco

Unraveling the Complex Links Between Obesity and Cancer: Risks and Prevention
Research & Development Unraveling the Complex Links Between Obesity and Cancer: Risks and Prevention

Imagine a world where obesity is not just a physical health challenge but a severe risk factor for life-threatening diseases. The increasing prevalence of obesity in modern society has become a significant concern for public health experts, especially with the stark rise in cancer cases. Delving

How Can CRISPR and Biomaterials Improve Gene Therapy Safety?
Biotech & Bioprocessing How Can CRISPR and Biomaterials Improve Gene Therapy Safety?

The integration of CRISPR technology with biomaterials engineering offers a promising avenue for safer and more effective gene therapies. Tomas Gonzalez-Fernandez, an assistant professor at Lehigh University, has received funding from the National Science Foundation’s Faculty Early Career

Can Retinal Imaging Revolutionize Stroke Risk Prediction?
Tech & Innovation Can Retinal Imaging Revolutionize Stroke Risk Prediction?

In a groundbreaking study, researchers have introduced a non-invasive method to predict stroke risk using a 'vascular fingerprint' identified in the retina, suggesting revolutionary potential for medical diagnostics. The method is detailed in the journal Heart, demonstrating that retinal markers

Can Bioprinted Tissues Revolutionize Treatments for Endocrine Diseases?
Biotech & Bioprocessing Can Bioprinted Tissues Revolutionize Treatments for Endocrine Diseases?

Aspect Biosystems, a pioneer in the field of bioprinted tissue therapeutics, recently closed a $115 million Series B financing round aimed at advancing its groundbreaking technology in regenerative medicine. This achievement, led by Dimension and supported by investors such as Novo Nordisk and

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later